Also trades as: GRF.MC (BME) · $vol 20M · GIFLF (OTC) · $vol 0M · GIFOF (OTC) · $vol 0M · GIKLY (OTC) · $vol 0M

$7.31

+0.01 (+0.14%)

Weekly Expected Move ±2.8%

$7 $7 $7 $8 $8

NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 36 · $6.2B mcap · 835M float · 0.075% daily turnover · Short 32% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$7.2B +0.2% ▲

5Y CAGR: +6.2%

Gross Profit

$2.6B -7.7% ▼

5Y CAGR: +2.7%

Operating Income

$1.2B -0.4% ▼

5Y CAGR: +3.6%

Net Income

$386M +146.1% ▲

5Y CAGR: -9.0%

EPS (Diluted)

$0.57 +147.8% ▲

5Y CAGR: -4.8%

EBITDA

$1.6B +9.1% ▲

5Y CAGR: +2.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$4.9B	$6.1B	$6.6B	$7.2B	$7.2B
YoY Growth	-7.6%	+22.9%	+8.7%	+9.4%	+0.2%
Cost of Revenue	$3.0B	$3.9B	$4.1B	$4.4B	$4.6B
Gross Profit	$2.0B	$2.2B	$2.5B	$2.8B	$2.6B
Gross Margin	39.8%	36.5%	37.7%	38.7%	35.7%
R&D Expenses	$355M	$361M	$395M	$384M	$358M
SG&A Expenses	$1.1B	$1.1B	$1.3B	$1.1B	$1.0B
Operating Expenses	$1.4B	$1.4B	$1.7B	$1.6B	$1.4B
Operating Income	$595M	$782M	$782M	$1.2B	$1.2B
Operating Margin	12.1%	12.9%	11.9%	16.5%	16.4%
Interest Expense	$234M	$445M	$516M	$773M	$600M
Income Before Tax	$350M	$338M	$207M	$444M	$591M
Tax Expense	$85M	$90M	$43M	$231M	$110M
Net Income	$189M	$185M	$42M	$157M	$386M
Net Margin	3.8%	3.1%	0.6%	2.2%	5.3%
EPS (Diluted)	$0.27	$0.31	$0.09	$0.23	$0.57
EBITDA	$944M	$1.2B	$1.2B	$1.5B	$1.6B
Shares Outstanding	682M	680M	680M	680M	681M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.8B	$2.0B	$1.8B	$1.9B	$1.9B	$2.0B	$1.7B	$1.9B
Cost of Revenue	$1.1B	$1.2B	$1.1B	$1.1B	$1.1B	$1.3B	$1.1B	$1.2B
Gross Profit	$727M	$766M	$705M	$744M	$752M	$680M	$630M	$704M
Gross Margin	40.5%	38.8%	39.5%	39.3%	40.3%	34.7%	36.5%	37.6%
R&D Expenses	$88M	$115M	$96M	$96M	$97M	$135M	$91M	$86M
SG&A Expenses	$319M	$158M	$315M	$283M	$274M	$273M	$286M	$289M
Operating Expenses	$410M	$395M	$436M	$395M	$368M	$408M	$377M	$375M
Operating Income	$317M	$372M	$269M	$349M	$383M	$272M	$253M	$329M
Operating Margin	17.7%	18.8%	15.1%	18.4%	20.5%	13.9%	14.6%	17.6%
Interest Expense	$198M	$16M	$154M	$141M	$156M	$158M	$141M	$80M
Income Before Tax	$119M	$211M	$115M	$191M	$198M	$110M	$114M	$247M
Tax Expense	$37M	$127M	$23M	$52M	$55M	-$15M	$24M	$64M
Net Income	$52M	$69M	$60M	$117M	$127M	$97M	$74M	$154M
Net Margin	2.9%	3.5%	3.3%	6.2%	6.8%	5.0%	4.3%	8.2%
EPS (Diluted)	$0.08	$0.10	$0.09	$0.17	$0.19	$0.14	$0.11	$0.23
EBITDA	$425M	$337M	$405M	$347M	$457M	$396M	$361M	$535M
Shares Outstanding	680M	680M	680M	689M	681M	681M	681M	681M

GRFS NASDAQ